vs
Aptorum Group Ltd(APM)与Lakeshore Acquisition III Corp.(LCCC)财务数据对比。点击上方公司名可切换其他公司
Lakeshore Acquisition III Corp.的季度营收约是Aptorum Group Ltd的1.6倍($717.3K vs $442.8K),Lakeshore Acquisition III Corp.净利率更高(67.9% vs -63.8%,领先131.7%)
Aptorum Group Ltd是一家跨国生物制药企业,专注于传染病、女性健康相关疾病和罕见病领域的创新治疗及诊断方案的研发、生产与商业化,核心运营市场覆盖北美及亚太多个国家和地区。
APM vs LCCC — 直观对比
营收规模更大
LCCC
是对方的1.6倍
$442.8K
净利率更高
LCCC
高出131.7%
-63.8%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $442.8K | $717.3K |
| 净利润 | $-282.5K | $486.8K |
| 毛利率 | — | — |
| 营业利润率 | -52.6% | -32.1% |
| 净利率 | -63.8% | 67.9% |
| 营收同比 | — | — |
| 净利润同比 | — | — |
| 每股收益(稀释后) | $-0.04 | $0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
APM
LCCC
| Q4 25 | $442.8K | — | ||
| Q3 25 | $208.8K | $717.3K | ||
| Q2 25 | — | $467.3K | ||
| Q2 23 | $431.4K | — |
净利润
APM
LCCC
| Q4 25 | $-282.5K | — | ||
| Q3 25 | $-614.0K | $486.8K | ||
| Q2 25 | — | $216.5K | ||
| Q2 23 | $-5.5M | — |
毛利率
APM
LCCC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 23 | 1.2% | — |
营业利润率
APM
LCCC
| Q4 25 | -52.6% | — | ||
| Q3 25 | -71.9% | -32.1% | ||
| Q2 25 | — | -53.7% | ||
| Q2 23 | — | — |
净利率
APM
LCCC
| Q4 25 | -63.8% | — | ||
| Q3 25 | -294.0% | 67.9% | ||
| Q2 25 | — | 46.3% | ||
| Q2 23 | -1272.0% | — |
每股收益(稀释后)
APM
LCCC
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $-0.09 | $0.08 | ||
| Q2 25 | — | $0.06 | ||
| Q2 23 | $-1.43 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $3.5M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $23.1M | $-1.6M |
| 总资产 | $18.7M | $71.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
APM
LCCC
| Q4 25 | $3.5M | — | ||
| Q3 25 | $56.8K | — | ||
| Q2 25 | — | — | ||
| Q2 23 | $340.3K | — |
股东权益
APM
LCCC
| Q4 25 | $23.1M | — | ||
| Q3 25 | $22.5M | $-1.6M | ||
| Q2 25 | — | $-1.4M | ||
| Q2 23 | $21.8M | — |
总资产
APM
LCCC
| Q4 25 | $18.7M | — | ||
| Q3 25 | $17.6M | $71.0M | ||
| Q2 25 | — | $70.5M | ||
| Q2 23 | $14.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-145.9K | $-206.3K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -0.42× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
APM
LCCC
| Q4 25 | $-145.9K | — | ||
| Q3 25 | $-484.3K | $-206.3K | ||
| Q2 25 | — | $-218.3K | ||
| Q2 23 | $-6.2M | — |
自由现金流
APM
LCCC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 23 | $-6.2M | — |
自由现金流率
APM
LCCC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 23 | -1436.3% | — |
资本支出强度
APM
LCCC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 23 | 0.7% | — |
现金转化率
APM
LCCC
| Q4 25 | — | — | ||
| Q3 25 | — | -0.42× | ||
| Q2 25 | — | -1.01× | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图